{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017053","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.596950+00:00","generated_at":"2026-05-18T15:13:40.538837+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Microbot Medical added to Russell Microcap Index effective June 30, 2025","bullets":["Added to the Russell Microcap Index as of market open on June 30, 2025, with automatic inclusion in growth and value style indexes.","CEO Harel Gadot cited strong execution, ongoing FDA 510(k) submission for LIBERTY, and anticipated Q3 commercial launch.","Membership is based on market-cap rankings; Russell indexes serve as benchmarks for about $10.6 trillion in assets (June 2024).","Microbot Medical (MBOT) is a pre-commercial endovascular robotics developer; LIBERTY is pending FDA 510(k) clearance."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017053","json":"https://secwatch.observer/filing/0001641172-25-017053.json","markdown":"https://secwatch.observer/filing/0001641172-25-017053.md","text":"https://secwatch.observer/filing/0001641172-25-017053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000164117225017053/0001641172-25-017053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000164117225017053/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T15:13:40.538837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}